Federated Hermes, Inc. Windtree Therapeutics Inc Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $1.14 $361 - $1,084	-951 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.94 - $1.6 $236 - $403	252 Added 36.05%	951 $1,000
Q4 2021 Feb 14, 2022	BUY	$1.4 - $2.31 $907 - $1,496	648 Added 1270.59%	699 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.66 - $2.27 $84 - $115	51 New	51 $1,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $34M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.